---
$id: https://graph.org.ai/products/commodity/51111768
$type: Product
source: UNSPSC
code: "51111768"
title: "Vindesine"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vindesine

**UNSPSC Code**: 51111768
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C43H55N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RSA8KO39WH, chemically known as vincaleukoblastine, 3-(aminocarbonyl)-o(sup 4)-deacetyl-3-de(methoxycarbonyl)- but generally known as vindesine, which bears US NIH Compound Identifier 40839. European Medicines Agency schedules Vindesine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00061MIG. The term VINDESINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules vindesine in its Anatomical Therapeutic Chemical (ATC) Classification. VINDESINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vindesine under HS 29399900 and SITC 54149. As of Q4 2014, VINDESINE remains the US FDA Preferred Term for this commodity. Vindesine bears US NLM identifiers UMLS ID C0042682 and NCI Concept Code C934. SMILES: OC1(C2N(C3C(C42C2N(CC4)CC=CC2(C1O)CC)CC(C(OC)C3)C1(CC2CC(O)(CN(C2)CCC2C1[NH]C1C2CCCC1)CC)C(=O)OC)C)C(=O)N.

